Former President Trump has announced a significant increase in tariffs, imposing a 100 percent levy on imported pharmaceuticals lacking U.S.-based manufacturing plants, alongside tariffs on household goods such as furniture. This move aims to bolster domestic production and address national security concerns regarding reliance on foreign pharmaceuticals, particularly affecting major exporters like India and Europe. Analysts predict rising prices for U.S. consumers and potential retaliatory measures from affected countries, complicating ongoing U.S.-India relations. The broader implications of these tariffs underscore the intersection of economic protectionism and geopolitical strategy, as the U.S. navigates its trade relationships amid escalating global tensions.